What’s good for Netflix is… good for the world? In January 2016, the streaming giant expanded its service to an additional 130 countries and territories, reaching more than 190 overnight. Now it’s ...

"While other entertainment companies pull back, we’re leaning in," the co-CEO writes about a report underscoring the company's expansive reach on the economy and culture. By Alex Weprin Senior Editor ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

This divide is demonstrated over on the Mass Effect Reddit page, where one of the top posts is a post about this very debate. And the divide is pretty much split down the middle. The post itself ...

“The moon we are looking at is not the moon you see from Earth whatsoever.” That’s how Artemis II astronaut Christina Koch described our natural satellite as the mission’s spacecraft drew closer to ...

A University of Pennsylvania analysis of over 400,000 posts from people taking GLP-1s found mentions of irregular periods, fatigue, chills, and hot flashes. A new study found Reddit users posting ...

The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, ...

Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Far fewer people who could ...

Lawsuits continue against makers of GLP-1 weight-loss drugs over side effects ranging from extreme vomiting to what some plaintiffs describe as “eye strokes,” according to multiple media reports.